This week we have had a lot of interest in our paper with over 3,000 views as the final part of the Lisbon trilogy.
What's the Lisbon Trilogy
Baker D, Herrod SS, Alvarez-Gonzalez C, Zalewski L, Albor C,
Schmierer K. Both cladribine and alemtuzumab may effect MS via B-cell depletion. Neurol, Neuroimmunol Neuroinflam
4:e360; doi:10.1212/NXI.0000000000000360: 2332-7812
ProfG was asked to give a talk on the mechanisms of Action of Antibodies in MS to a group of Antibody Engineers.
ProfG could not attend so he asked me to do it, gave me his 75 slides for a 30min talk.....No chance.
I had a few weeks to construct a story and plan my slides
So I thought, could I explain how natalizumab, daclizumab, alemtuzumab and ocrelizumab work?
Starting with daclizumab as the odd one out and having the details of of the alemtuzumab and cladribine to hand this is what the audience got.
There was one Neurologist in the Room.